Brief: Moleculin Biotech Granted Two Additional U.S. Patents For Annamycin
05/05/2025 14:28
May 5 (Reuters) - Moleculin Biotech Inc MBRX.O: MOLECULIN BIOTECH INC - GRANTED TWO ADDITIONAL U.S. PATENTS FOR ANNAMYCIN MOLECULIN BIOTECH INC - PATENTS EXTEND UNTIL JUNE 2040 Source text: ID:nGNX1Nzwk5 Further company coverage: MBRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Moleculin Biotech
See all newsMoleculin Biotech Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Moleculin Secures Australian Patent For Annamycin Formulation Technology
Moleculin Biotech Inc expected to post a loss of $8.87 a share - Earnings Preview
Brief: Moleculin Biotech Completes Dosing In Part A Of Miracle Trial Data Readout On Track For Q1 2027
NASDAQ RESUMED AT 09:00 AM